Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Consensus Recommendation of “Buy” by Analysts

Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have earned an average rating of “Buy” from the thirteen research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, ten have given a buy recommendation and two have given a strong buy […]

Leave a Reply

Your email address will not be published.

Previous post APi Group Co. (NYSE:APG) Receives Consensus Rating of “Moderate Buy” from Brokerages
Next post Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of “Moderate Buy” from Brokerages